PHCbi will exhibit LiCellGrow™ at the 25th Congress of the Japanese Society for Regenerative Medicine, March 19-20 at the ...

Global health officials mandate a new flu vaccine to combat a late-emerging, severe H3N2 variant, as current shots proved 37% ...

Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic material that determines ...

There are growing calls to allow prisoners greater access to phones – with current rules allowing for one five-minute phone ...

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as ...

The preclinical pharmacokinetic (PK) and pharmacodynamic (PD) studies, conducted in cynomolgus monkeys following subcutaneous and intravenous administration, demonstrated rapid downregulation of the ...

The MajesTEC-1 trial (NCT04557098) 1,2 focusing on the bispecific antibody teclistamab (Tecvayli), stands as a landmark study in this space. Conducted during the unique logistical and clinical ...

Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for ...

Geneticist and entrepreneur Adrian Woolfson argues that genome engineering and AI will let us design organisms beyond nature’s limits ...

Go to Profile icon > Settings > Navigation settings and make sure Show raised buildings is turned on. After that, switch it on from the map itself. Tap the Layers icon (the stacked squares) in the top ...

While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

New therapeutics in development for autoimmune disease and oncologyLead therapeutic BRZ-101 designed to restore immune tolerance in type 1 diabetes, advancing into IND-enabling studiesExpanding ...